Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma

Background: Hyperprogressive disease (HPD) rate in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI) was determined using tumor growth kinetics (TGK) and compared with rapidly progressive screen-failure (SF) patients. The impact of TGK on outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Karabajakian, Andy, Garrivier, Thibaut, Crozes, Carole, Gadot, Nicolas, Blay, Jean-Yves, Bérard, Frédéric, Céruse, Philippe, Zrounba, Philippe, Saintigny, Pierre, Mastier, Charles, Fayette, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210015/
https://www.ncbi.nlm.nih.gov/pubmed/32405337
http://dx.doi.org/10.18632/oncotarget.27563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210015/
https://www.ncbi.nlm.nih.gov/pubmed/32405337
http://dx.doi.org/10.18632/oncotarget.27563

Ejemplares similares